| 1 |
Efficient Biotransformation of Astragaloside IV to Cycloastragenol by Bacillus sp LG-502
Wang LM, Chen Y
Applied Biochemistry and Biotechnology, 183(4), 1488, 2017 |
| 2 |
Astragaloside IV inhibits progression of glioma via blocking MAPK/ERK signaling pathway
Li B, Wang F, Liu NT, Shen W, Huang T
Biochemical and Biophysical Research Communications, 491(1), 98, 2017 |
| 3 |
Astragaloside IV suppresses transforming growth factor-beta 1 induced fibrosis of cultured mouse renal fibroblasts via inhibition of the MAPK and NF-kappa B signaling pathways
Che XJ, Wang Q, Xie YY, Xu WJ, Shao XH, Mou S, Ni ZH
Biochemical and Biophysical Research Communications, 464(4), 1260, 2015 |
| 4 |
EGFR mediates astragaloside IV-induced Nrf2 activation to protect cortical neurons against in vitro ischemia/reperfusion damages
Gu DM, Lu PH, Zhang K, Wang X, Sun M, Chen GQ, Wang Q
Biochemical and Biophysical Research Communications, 457(3), 391, 2015 |
| 5 |
A novel biotransformation of astragalosides to astragaloside IV with the deacetylation of fungal endophyte Penicillium canescens
Yao ML, Liu JZ, Jin S, Jiao J, Gai QY, Wei ZF, Fu YJ, Zhao JT
Process Biochemistry, 49(5), 807, 2014 |
| 6 |
Microbial transformation of astragalosides to astragaloside IV by Absidia corymbifera AS2
Ye L, Liu XH, Zhou W, Feng MQ, Shi XL, Li JY, Chen DF, Zhou P
Process Biochemistry, 46(9), 1724, 2011 |
| 7 |
Astragaloside IV and polysaccharide production by hairy roots of Astragalus membranaceus in bioreactors
Du M, Wu XJ, Ding J, Hu ZB, White KN, Branford-White CJ
Biotechnology Letters, 25(21), 1853, 2003 |
